Raymond James & Associates Anixa Biosciences Inc Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

A detailed history of Raymond James & Associates transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Raymond James & Associates holds 15,752 shares of ANIX stock, worth $44,420. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,752

Previous 17,755 11.28%

Holding current value

$44,420

Previous $39,000 25.64%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$2.21 - $3.48 $4,426 - $6,970	-2,003 Reduced 11.28%	15,752 $49,000
Q1 2024 Apr 22, 2024	SELL	$3.08 - $5.02 $116,713 - $190,227	-37,894 Reduced 68.09%	17,755 $55,000
Q4 2023 Jan 16, 2024	SELL	$2.85 - $4.19 $2,659 - $3,909	-933 Reduced 1.65%	55,649 $215,000
Q3 2023 Oct 24, 2023	BUY	$2.97 - $3.87 $297 - $387	100 Added 0.18%	56,582 $185,000
Q2 2023 Jul 25, 2023	SELL	$3.0 - $5.97 $1,401 - $2,787	-467 Reduced 0.82%	56,482 $180,000
Q1 2023 Apr 14, 2023	SELL	$3.86 - $5.0 $1,034 - $1,340	-268 Reduced 0.47%	56,949 $244,000
Q4 2022 Feb 08, 2023	SELL	$3.78 - $5.81 $13,717 - $21,084	-3,629 Reduced 5.96%	57,217 $243,000
Q3 2022 Oct 25, 2022	SELL	$2.81 - $6.15 $13,128 - $28,732	-4,672 Reduced 7.13%	60,846 $299,000
Q2 2022 Aug 12, 2022	SELL	$2.55 - $4.1 $127 - $204	-50 Reduced 0.08%	65,518 $200,000
Q1 2022 May 11, 2022	BUY	$2.5 - $3.42 $21,665 - $29,637	8,666 Added 15.23%	65,568 $180,000
Q4 2021 Feb 08, 2022	BUY	$2.88 - $5.5 $15,413 - $29,436	5,352 Added 10.38%	56,902 $169,000
Q3 2021 Nov 02, 2021	SELL	$3.57 - $5.6 $8,946 - $14,033	-2,506 Reduced 4.64%	51,550 $246,000
Q2 2021 Aug 11, 2021	BUY	$3.46 - $4.92 $40,571 - $57,691	11,726 Added 27.7%	54,056 $210,000
Q1 2021 May 14, 2021	BUY	$3.27 - $7.14 $138,419 - $302,236	42,330 New	42,330 $198,000
Q2 2020 Jul 28, 2020	SELL	$1.53 - $3.06 $15,361 - $30,722	-10,040 Closed	0 $0
Q2 2019 Aug 06, 2019	BUY	$3.47 - $4.75 $34,838 - $47,690	10,040 New	10,040 $36,000

Others Institutions Holding ANIX

# of Institutions

Shares Held

5.53M

Call Options Held

21K

Put Options Held

6.7K

View Full List

About Anixa Biosciences Inc

Ticker ANIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,661,700
Market Cap $86.5M
Description
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...

More about ANIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Anixa Biosciences Inc Transaction History